Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

13.53 +1.20 (+9.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,536,181
Open 12.40
Bid (Size) 13.53 (2)
Ask (Size) 13.60 (1)
Prev. Close 12.33
Today's Range 12.06 - 13.87
52wk Range 8.790 - 32.10
Shares Outstanding 41,969,994
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Many healthcare names are attractive. But drugstore chains and some drug makers have poor outlooks. Here are three healthcare stocks to sell. 
Via InvestorPlace
Top 5 Health Care Stocks That May Explode In July
Via Benzinga

Performance

YTD
-39.65%
-39.65%
1 Month
-31.94%
-31.94%
3 Month
-35.66%
-35.66%
6 Month
-47.44%
-47.44%
1 Year
-38.28%
-38.28%

More News

Read More
3 Biotech Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Cassava Sciences Stock Is Sinking Today
Via The Motley Fool
Peering Into Cassava Sciences's Recent Short Interest
Via Benzinga
Planet Labs Layoffs 2024: What to Know About the Latest Planet Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Are Stocks Down Today?
Via InvestorPlace
SAVA Stock Alert: Former Cassava Science Advisor Charged With Fraud
Via InvestorPlace
Cassava Shares Are Down Over 30%: Here's Why
Via Benzinga
Cassava Sciences Issues Statement on Former Science Advisor
From Cassava Sciences, Inc.
Via GlobeNewswire
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
SAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024
Via InvestorPlace
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
From Cassava Sciences, Inc.
Via GlobeNewswire
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
From Cassava Sciences, Inc.
Via GlobeNewswire
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
From Cassava Sciences, Inc.
Via GlobeNewswire
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks
Via InvestorPlace
Redemption Date Announced for Warrants
From Cassava Sciences, Inc.
Via GlobeNewswire
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Cassava Sciences, Inc. with Losses of $100,000 to Contact the Firm
From Schall Law
Via GlobeNewswire
SAVA FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.